Evidence map›Paper›PMID 34162535›Full record

ArticleScience advances2021

Ciliopathy protein HYLS1 coordinates the biogenesis and signaling of primary cilia by activating the ciliary lipid kinase PIPKIγ.

Chuan Chen, Qingwen Xu, Yuxia Zhang, Brian A Davies, Yan Huang, David J Katzmann, Peter C Harris, Jinghua Hu, Kun Ling

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Ciliary Membrane Lipid Homeostasis in Health and Disease.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. A Ciliary Phosphoinositide Pathway Regulates the Dosage of Polycystins in Primary Cilia.Journal of the American Society of Nephrology : JASN · 2026
    Article
  3. Article
  4. Research progress of kinesin family in neurological diseases.Frontiers in cellular neuroscience · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Chuan ChenDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0002-0694-0867
Qingwen XuDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0002-4796-3141
Yuxia ZhangDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
Brian A DaviesDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
Yan HuangDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
David J KatzmannDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
Peter C HarrisDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
Jinghua HuDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0001-9635-9779
Kun LingDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA. ling.kun@mayo.edu.ORCID 0000-0002-2388-5492
Mayo Clinic · US

Funding

Pilot and FeasibilityP30DK090728 · NIDDK · MAYO CLINIC ROCHESTER · PI TORRES, VICENTE E · 2010 to 2019
$11.8M
Research BaseP30DK090868 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI WATNICK, TERRY J · 2010 to 2019
$11.1M
Molecular dissection of the ciliary gateR01DK099160 · NIDDK · MAYO CLINIC ROCHESTER · PI Jinghua Hu · 2014 to 2026
$4.0M
Exploration of the functions of the ciliopathy Arls in cilia.R01DK090038 · NIDDK · MAYO CLINIC ROCHESTER · PI HU, JINGHUA · 2011 to 2019
$3.1M
A novel cilium-to-nucleus axis promotes cellular senescenceR01AG076469 · NIA · MAYO CLINIC ROCHESTER · PI Jinghua Hu · 2022 to 2026
$1.6M
Regulation of Vps4 during ESCRT functionR01GM116826 · NIGMS · MAYO CLINIC ROCHESTER · PI KATZMANN, DAVID J · 2016 to 2019
$1.4M
NIA NIH HHS R01 AG076469NIDDK NIH HHS P30 DK090728NIDDK NIH HHS P30 DK090868NIDDK NIH HHS P30 DK90728NIDDK NIH HHS R01 DK090038NIDDK NIH HHS R01 DK099160NIGMS NIH HHS R01 GM116826
6 · The paper itself

Abstract

Mutation of ciliopathy protein HYLS1 causes the perinatal lethal hydrolethalus syndrome (HLS), yet the underlying molecular etiology and pathogenesis remain elusive. Here, we reveal unexpected mechanistic insights into the role of mammalian HYLS1 in regulating primary cilia. HYLS1 is recruited to the ciliary base via a direct interaction with the type Iγ phosphatidylinositol 4-phosphate [PI(4)P] 5-kinase (PIPKIγ). HYLS1 activates PIPKIγ by interrupting the autoinhibitory dimerization of PIPKIγ, which thereby expedites depletion of centrosomal PI(4)P to allow axoneme nucleation. HYLS1 deficiency interrupts the assembly of ciliary NPHP module and agonist-induced ciliary exit of β-arrestin, which, in turn, disturbs the removal of ciliary Gpr161 and activation of hedgehog (Hh) signaling. Consistent with this model of pathogenesis, the HLS mutant HYLS1

Indexed as

CiliaCiliopathiesAnimalsFemaleHand Deformities, CongenitalHeart Defects, CongenitalHedgehog ProteinsHydrocephalusMammalsPregnancySignal TransductionHedgehog Proteins

Identifiers

PMID34162535
PMCPMC8221637
OpenAlexW3175217268

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.